At Editas Medicine, our mission and commitment is to harness the power and potential of CRISPR gene editing to develop a robust pipeline of medicines for people living with serious diseases around the world. Our goal is to discover, develop, manufacture, and commercialize transformative, durable genomic medicines for many diseases. The primary focus of this role in the next 12 months is to advance our lead in vivo development candidate, EDIT-401, by leading program strategy and driving disciplined, cross-functional execution, proactively managing risk, and ensuring alignment between scientific ambition and operational reality. EDIT-401 is a potential best-in-class, one-time therapy designed to significantly reduce LDL cholesterol levels. This is a critical and highly visible role, making a substantial contribution to the company, with the opportunity to expand as pipeline therapies advance in development.
Stand Out From the Crowd
Upload your resume and get instant feedback on how well it matches this job.
Job Type
Full-time
Career Level
Senior